Clinical Trials Logo

Clinical Trial Summary

This prospective, surveillance study will assess the operational Zika virus definition for use in future Zika purified inactivated virus (ZIKV) vaccine efficacy trials in order to identify Zika virus disease (ZVD) cases among the study cohort.


Clinical Trial Description

This prospective, multicenter, cohort study will conduct active and passive surveillance for ZVD and determine its prevalence and seroconversion incidence in areas of Latin America experiencing Zika epidemic activity. A description of the occurrence of dengue virus and chikungunya virus infections in the cohort may also be provided as differential diagnosis of ZVD. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03158233
Study type Observational
Source Sanofi
Contact
Status Completed
Phase
Start date April 29, 2017
Completion date December 19, 2018

See also
  Status Clinical Trial Phase
Completed NCT03343626 - Safety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Participants Phase 1
Completed NCT03624946 - Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG) Phase 1
Completed NCT02733796 - Persistence of Zika Virus in Semen After Acute Infection